Antiva Biosciences
Phase 1Antiva is developing novel topical therapies to treat pre-cancerous lesions caused by HPV.
Founded
2012
Focus
Small Molecules
About
Antiva is developing novel topical therapies to treat pre-cancerous lesions caused by HPV.
Funding History
7Total raised: $232M
Series E$53MUndisclosedApr 27, 2023
Series C$53MBrace Pharma CapitalJan 15, 2020
Series C$30MRiverVest Venture PartnersJun 15, 2018
Series B$30MNew Enterprise AssociatesSep 15, 2017
Company Info
TypePrivate
Founded2012
LocationSan Francisco, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile